CLEC9A and neoplasm: (21), we tested 11 APC-binding molecules (CCL3, CCL4, CCL5, CCL19, CCL20, CCL21, XCL1, GM-CSF, Fv αDEC205, Fv αClec9a, and Clec9a ligand) for their ability to increase the immunogenicity and anti-tumor effect of five in silico predicted murine cancer neoepitopes.